• HUDA N AL-ANI Department of Chemistry, College of Science, University of Baghdad, Jadiriya, Baghdad, Iraq.


Objective: Chelating therapy is a medical procedure that involves the administration of chelating agents to remove heavy metals from the body; chelating agents detoxify heavy metals and toxins, converting them to inactive forms which were excreted out from the body. This work demonstrates the complication of the drug with toxic heavy metal lead (Π) ion.

Methods: All the experiments were performed at different temperature (303, 308, 313, 318, and 323) °K, by spectrophotometric method. The electronic spectra of the mixture of drug and lead ion show a bathochromic (red) shift in ʎmax, the absorbance change caused by a complex arrangement between the lead ion and drug.

Results: The stoichiometry of the complex formed was calculated using continuous variation method, it was found (1:2) that the durability constant was estimated that the standard thermodynamic parameters ΔH°, ΔG°, and ΔS° were determined, the negative values of free energy changes ΔG° indicate a spontaneous complexation process. The positive values of enthalpy change indicate an endothermic process with an increase in entropy change ΔS° (positive), that means the process in an entropy driven.

Conclusion: The kinetic studies of the complexation of drug and ion were found to follow the second-order reaction, which was confined by the straight line and a high rate constant.

Keywords: Chelating therapy, Complexation, Stoichiometry, Kinetic, drug


1. Lehninger AL. Phys Rev 1990;30:393.
2. Richards FM, Wyckoff HM, Allewel NM. Neurosciences1969 ;???:901.
3. Thomas G. Medicinal Chemistry. London: John Wiley and Son Ltd.;2003. p. 256.
4. Mukharjee GN, Ghosh TK. Indian J Chem 1991;30A:1033-7.
5. Mukharjee GN, Ghosh TK. J Indian Chem Soc 1991;68:194-6.
6. Vogel’s Text book of Quantitative Chemical Analysis. 6th ed. Singapore:Pears Edu Ltd.; 1989.
7. Belliardo F, Martelli A, Valle MG. HPLC determination of caffeine and theophylline in Paullinia cupana Kunth (Guarana) and Cola spp. Samples. Z Lebensm Unters Forsch 1985;180:398-401.
8. Persson CG. Development of safer xanthine drugs for treatment of obstructive airways disease. J Allergy Clin Immunol 1986;78:817-24.
9. Barnes PJ. Theophylline: New perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-8.
10. Schubert J. Interaction of metals with small molecules in relation to metal-protein complexes. In: Gurd FR, editor. Chemical Specificity in Biological Interactions. New York: Academic Press; 1954.
11. Jadhav SH, Sarkar SN, Patil RD, Tripathi HC. Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: A biochemical and histopathological study in male rats. Arch Environ Contam Toxicol 2007;53:667-77.
12. Patra RC, Swarup D. Effect of lead on erythrocytic antioxidant defence, lipid peroxide level and Thiol groups in calves. Res Vet Sci 2000;68:71-4.
13. Gurer H, Neal R, Yang P, Oztezcan S, Ercal N. Captopril as an antioxidant in lead-exposed Fischer 344 rats. Hum Exp Toxicol 1999;18:27-32.
14. Ahearn GA, Mandal PK, Mandal A. Mechanisms of heavy-metal sequestration and detoxification in crustaceans: A review. J Comp Physiol B 2004;174:439-52.
15. Bard AJ, Flultener LR. Electrochemical methods fundamentals and applications. New York: John Wiley and Sons Inc.; 1980.
16. Peter P. Formation and stability of inorganic complex in solution. Anal Chem 1998;9:113-203.
17. Huned YJ. Study of the interaction between mono ammonium glycyrrhizin ate and bovine serum albumin. J Pharm Biomed Anal 2004;36:915-9.
18. Huned YJ. Studies on the interaction between 1-hexylcarbamoyl- 5-flurouracil and bovine serum albumin. J Mol Stricter 2005;738: 143-7.
19. Maccarthy K, Patrick D. Novel approach to Jop’s methods. J Chem Educ 1986;63:162-7.
20. Bakhle YS. COX-2 and cancer: A new approach to an old problem. Br J Pharmacol 2001;134:1137-50.
21. Combaret L. Molecular mechanisms in exercise-induced cardio protection. J Physiol 2000;569:123-7.
22. Gibson RE, Loeffle OE. Absorption and luminescence of aromatic molecules. Am Chem Soc 2000;62:1324.
23. Stephen L. Chem1 Virtual. 2nd ed. Canada: Burnaby Vancouver; 2004.
24. Ewing GW. Instrumental Methods of Chemical Analysis. New York: McGraw-Hill Inc.; 1990.
25. Kieffer F. In: Merian G, editor. Metals and Compounds in the Environment. Weinheim: VCH; 1991. p. 481.
26. Atikins PW. Physical Chemistry. 8th ed. Oxford, Chicago: Oxford University Press; 2006.
27. Karlsson BC, Rosengren AM, Andersson PO, Nicholls IA. The spectrophysics of warfarin: Implications for protein binding. J Phys Chem B 2007;111:10520-8.
28. Morris S. Chemical Kinetics. New Delhi: IVY Publishing House, Sarup and Sons; 2003. p. 2-30.
29. Inczedy J. Analytical Applications of Complex Equilibrium. New York: John Wiley and Sons; 1996.
30. Onkari DD, Chawda MB, Thakur KS, Pawan K. Evaluation hypolipidemic activity of arogyavardhini and zpter tablet in cholesterol-rich high fat diet (hfd) induced hyperlipidemia in Wistar rats. Int J Pharm Pharm Sci 2019;11:1-5.
31. Pisal P, Nigade G, Kale A, Pawar S. Development and validation of stability indicating rp-hplc method for simultaneous determination of aspirin, rosuvastatin, clopidogrel in bulk and pharmaceutical dosage form. Int J Pharm Pharm Sci 2018;10:51-6.
156 Views | 53 Downloads
How to Cite
HUDA N AL-ANI. “THERMODYNAMIC AND KINETIC STUDIES FOR THE BINDING OF LEAD ION BY CHELATING WITH THEOPHYLLINE 1,3-DIMETHYLXANTHINE (THERAPY DRUG)”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 8, July 2019, pp. 277-83, doi:10.22159/ajpcr.2019.v12i18.34085.
Original Article(s)